SCHEMBL15920967

SCHEMBL15920967

COc1ccc(-c2c3c(c(O)c4cc(OC)c(OC)cc24)COC3=O)cc1OC

nearest known ligand 0.77

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.77
ALDH1A1 P00352 3/20 0.77
MAPT P10636 3/20 0.77
LMNA P02545 3/20 0.77
NPSR1 Q6W5P4 2/20 0.77
MEN1 O00255 2/20 0.77
HPGD P15428 2/20 0.77
KMT2A Q03164 2/20 0.77
HTT P42858 1/20 0.77
TOP2A P11388 1/20 0.53
CYP19A1 P11511 3/20 0.51
ALOX5 P09917 1/20 0.47
PDE1A P54750 2/20 0.46
PDE1B Q01064 2/20 0.46
PDE3B Q13370 2/20 0.46
PDE1C Q14123 2/20 0.46
PDE3A Q14432 2/20 0.46
PDE5A O76074 1/20 0.46
PDE4A P27815 1/20 0.46
PDE4B Q07343 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17280352 0.94 KDM4E (0.69) KDM4EALDH1A1MAPTLMNANPSR1
SCHEMBL4096679 0.93 KDM4E (0.85) KDM4EALDH1A1MAPTLMNANPSR1
SCHEMBL15920662 0.89 MAPT (0.72) KDM4EALDH1A1MAPTLMNANPSR1
SCHEMBL15920749 0.89 ALDH1A1 (0.71) KDM4EALDH1A1MAPTLMNANPSR1
SCHEMBL15920805 0.88 KDM4E (0.71) KDM4EALDH1A1MAPTLMNANPSR1
Diphyllin SCHEMBL30887017 0.87 ALDH1A1 (1.00) KDM4EALDH1A1MAPTLMNANPSR1
Diphyllin SCHEMBL1061765 0.87 ALDH1A1 (1.00) KDM4EALDH1A1MAPTLMNANPSR1
Cilinaphthalide B SCHEMBL15920690 0.86 MAPT (0.63) KDM4EALDH1A1MAPTLMNANPSR1
SCHEMBL15920747 0.86 ALDH1A1 (0.68) KDM4EALDH1A1MAPTLMNANPSR1
SCHEMBL15920776 0.86 MAPT (0.68) KDM4EALDH1A1MAPTLMNANPSR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9650355-B2 Method for preparation of justicidin a derivatives of arylnaphthalene lignan structure KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-16 US claimed
WO-2014119892-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-08-07 WO claimed
US-9650355-B2 Method for preparation of justicidin a derivatives of arylnaphthalene lignan structure KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-16 US disclosed
US-9650355-B2 Method for preparation of justicidin a derivatives of arylnaphthalene lignan structure KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2017-05-16 US disclosed
US-20150336938-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-11-26 US disclosed
US-20150336938-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2015-11-26 US disclosed
WO-2014119892-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-08-07 WO disclosed
WO-2014119892-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2014-08-07 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20150336938-A1 METHOD FOR PREPARATION OF JUSTICIDIN A DERIVATIVES OF ARYLNAPHTHALENE LIGNAN STRUCTURE UGT1A8, NOTUM, MLN KDM4E 3104/4885ALDH1A1 241/4885MAPT 3028/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.